Medline hit with FDA warning letter over angiographic syringe manufacturing failures
An FDA inspection of Medline’s facilities in December 2025 found that the company fell short of certain good manufacturing practice…

An FDA inspection of Medline’s facilities in December 2025 found that the company fell short of certain good manufacturing practice…
The randomised controlled, multi-centre, prospective trial will enrol 1,025 patients across multiple centres in the US.
An FDA inspection of Medline’s facilities in December 2025 found that the company fell short of certain good manufacturing practice…
The randomised controlled, multi-centre, prospective trial will enrol 1,025 patients across multiple centres in the US.
CorTec's BCI aims to differentiate itself by offering brain-based communication alongside therapeutic neurostimulation.
AI Airlock is jointly run by the MHRA, DHSC, NHS AI Team, and Team AB, the consortium of UK Approved…
Research suggests that over 120,000 patients suffer from aortic arch disease in the US and Europe annually, but only around…
The proceeds will support Route 92’s growth strategy through expediting worldwide commercial expansion.
FDA-cleared in December 2025, E2’s Hēlo system is indicated for the non-surgical removal of emboli and thrombi from pulmonary arteries…
Varipulse Pro introduces a new pulse sequence with lower temperature and five times faster ablation.
TRiCares' pivotal trial will build on an ongoing early feasibility study of the Topaz TTVR system that began in January…
Barnes-Jewish Hospital is set to conduct the initial live case using the EggNest Complete Flex system.
Learn more about Alleima’s life changing medical-solutions